Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bergner, Bockorny, Castagnetti & Hawkins was a prominent Washington, D.C.-based government relations and lobbying firm that specialized in representing clients within the healthcare, biotechnology, and pharmaceutical sectors. Active primarily during the 1990s and early 2000s, the firm provided strategic political counsel and legislative advocacy for major organizations such as Sanofi, the American Hospital Association, and the Council for Responsible Nutrition. The firm played a key role in navigating complex regulatory landscapes and shaping federal policy related to drug development, healthcare reimbursement, and dietary supplement regulation. Following its dissolution, the founding partners went on to establish other influential lobbying entities, including the Bockorny Group and Mehlman Castagnetti Rosen & Thomas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bergner, Bockorny, Castagnetti & Hawkins.